C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection

Transplantation

Volumn 89, Issue 12, 2010, Pages 1471-1475

  Hönger, Gideon ^a   Wahrmann, Markus ^b   Amico, Patrizia ^a   Hopfer, Helmut ^c   Böhmig, Georg A ^b   Schaub, Stefan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antibody mediated rejection; C4d; Complement activation; HLA antibodies

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES; BIOPSY; CAPILLARIES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES;

EID: 77954089708     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181dc13e7     Document Type: Article

References (24)

1. Amico P, Honger G, Mayr M, et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681.
2. Gupta A, Iveson V, Varagunam M, et al. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? Transplantation 2008; 85: 1200.
3. van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086.
4. Patel AM, Pancoska C, Mulgaonkar S, et al. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7: 2371.
5. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684.
6. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
7. Wahrmann M, Exner M, Regele H, et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 2003; 275: 149.
8. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, luminex binding antibodies\A new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
9. Bartel G, Wahrmann M, Exner M, et al. In vitro detectionof C4d-fixing HLA alloantibodies: Associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008; 8: 41.
10. Wahrmann M, Bartel G, Exner M, et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009; 22: 982.
11. Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242.
12. Seemayer CA, Gaspert A, Nickeleit V, et al. C4d staining of renal allo-graft biopsies: A comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568.
13. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expressioninkidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
14. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
15. Kushihata F, Watanabe J, Mulder A, et al. Human leukocyte antigen antibodies and human complement activation: Role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004; 78: 995.
16. Bartel G, Wahrmann M, Exner M, et al. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007; 83: 727.
17. Arnold ML, Dechant M, Doxiadis II, et al. Prevalence and specificity of immunoglobulin Gand immunoglobulinA non-complement-binding anti-HLA alloantibodies in retransplant candidates. Tissue Antigens 2008; 72: 60.
18. Arnold ML, Zacher T, Dechant M, et al. Detection and specification of noncomplement binding anti-HLA alloantibodies. Hum Immunol 2004; 65: 1288.
19. Tambur AR, Ramon DS, Kaufman DB, et al. Perception versus reality?: Virtual crossmatch\How to overcome some of the technical and logistic limitations. Am J Transplant 2009; 9: 1886.
20. Nikaein A, Cherikh W, Nelson K, et al. Organ procurement and transplantation network/united network for organ sharing histocompatibil-ity committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Transplantation 2009; 87: 557.
21. Vaidya S, Partlow D, Susskind B, et al. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006; 82: 1524.
22. Bielmann D, Honger G, Lutz D, et al. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007; 7: 626.
23. Cai J, Terasaki PI, Anderson N, et al. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009; 88: 226.
24. El-Awar N, Terasaki PI, Nguyen A, et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009; 70: 844.